Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Tracking Spending on Malaria by Source in 106 Countries, 2000–16: An Economic Modelling Study Publisher Pubmed



Haakenstad A1 ; Harle AC2 ; Tsakalos G2 ; Micah AE2 ; Tao T2 ; Anjomshoa M3, 4, 9 ; Cohen J1 ; Fullman N2 ; Hay SI2 ; Mestrovic T5, 6 ; Mohammed S7, 8 ; Mousavi SM9 ; Nixon MR2 ; Pigott D2 Show All Authors
Authors
  1. Haakenstad A1
  2. Harle AC2
  3. Tsakalos G2
  4. Micah AE2
  5. Tao T2
  6. Anjomshoa M3, 4, 9
  7. Cohen J1
  8. Fullman N2
  9. Hay SI2
  10. Mestrovic T5, 6
  11. Mohammed S7, 8
  12. Mousavi SM9
  13. Nixon MR2
  14. Pigott D2
  15. Tran K10, 11
  16. Murray CJL2
  17. Dieleman JL2
Show Affiliations
Authors Affiliations
  1. 1. Harvard T H Chan School of Public Health, Boston, MA, United States
  2. 2. Institute for Health Metrics and Evaluation, Seattle, WA, United States
  3. 3. Rafsanjan University of Medical Sciences Social Determinants of Health Research Center, Rafsanjan, Iran
  4. 4. Department of Health Management and Economics, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Dr Zora Profozic Polyclinic Clinical Microbiology and Parasitology Unit, Zagreb, Croatia
  6. 6. University Centre Varazdin, Varazdin, Croatia
  7. 7. Ahmadu Bello University, Zaria, Nigeria
  8. 8. Heidelberg University Institute of Public Health, Heidelberg, Germany
  9. 9. Tehran University of Medical Sciences Department of Health Management and Economics, Tehran, Iran
  10. 10. University of Auckland Department of Molecular Medicine and Pathology, Auckland, New Zealand
  11. 11. Military Medical University Department of Clinical Hematology and Toxicology, Hanoi, Viet Nam

Source: The Lancet Infectious Diseases Published:2019


Abstract

Background: Sustaining achievements in malaria control and making progress toward malaria elimination requires coordinated funding. We estimated domestic malaria spending by source in 106 countries that were malaria-endemic in 2000–16 or became malaria-free after 2000. Methods: We collected 36 038 datapoints reporting government, out-of-pocket (OOP), and prepaid private malaria spending, as well as malaria treatment-seeking, costs of patient care, and drug prices. We estimated government spending on patient care for malaria, which was added to government spending by national malaria control programmes. For OOP malaria spending, we used data reported in National Health Accounts and estimated OOP spending on treatment. Spatiotemporal Gaussian process regression was used to ensure estimates were complete and comparable across time and to generate uncertainty. Findings: In 2016, US$4·3 billion (95% uncertainty interval [UI] 4·2–4·4) was spent on malaria worldwide, an 8·5% (95% UI 8·1–8·9) per year increase over spending in 2000. Since 2000, OOP spending increased 3·8% (3·3–4·2) per year, amounting to $556 million (487–634) or 13·0% (11·6–14·5) of all malaria spending in 2016. Governments spent $1·2 billion (1·1–1·3) or 28·2% (27·1–29·3) of all malaria spending in 2016, increasing 4·0% annually since 2000. The source of malaria spending varied depending on whether countries were in the malaria control or elimination stage. Interpretation: Tracking global malaria spending provides insight into how far the world is from reaching the malaria funding target of $6·6 billion annually by 2020. Because most countries with a high burden of malaria are low income or lower-middle income, mobilising additional government resources for malaria might be challenging. Funding: The Bill & Melinda Gates Foundation. © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Experts (# of related papers)